Form D · Biotechnology
VisionScope Technologies LLC
Concord, MA · CIK 0001412014
Offering snapshot reported Feb 15, 2011 · SEC filing
- Reported sold
- $6.3M Offering amount: $6.3M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 4, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2011 | Initial | $6,300,000 | No comparison | 27 | SEC filing |
| Apr 17, 2009 | Initial | $4,000,000 | No comparison | Not reported | SEC filing |
| Sep 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155374
Source: Form D, filed Feb 15, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Blumenthal | Director |
| Lim Cheung | Executive |
| William F Doyle | Director |
| Valerie Jo Friedman | Director |
| Thomas Gill | Director, Executive |
| Roger Kitterman | Director |
| Timothy Langloss | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2352 Main Street, Suite 303
Concord, MA, 01742
Concord, MA, 01742